Ganweikang Tablet Attenuates the NAFL and NASH by Inhibiting Inflammation, Apoptosis and Enhancing Fatty Acid Oxidation Through Inhibiting NFκB and caspase8 and Activating PPARα. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.